Enzyme replacement therapy in mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)
Paul Harmatz, Chester B. Whitley, Lewis J. Waber et al. · The Journal of Pediatrics · 2004
Cited by 272 works. doi:10.1016/j.jpeds.2004.03.018
Authors
- Paul Harmatz
- Chester B. Whitley
- Lewis J. Waber
- Ray C. Pais
- Robert D. Steiner
- Barbara Plecko
- Paige B. Kaplan
- Julie Simon
- Ellen Butensky
- John J. Hopwood
References
- The Metabolic Basis of Inherited Disease
- Prevalence of Lysosomal Storage Disorders
- The metabolic basis of inherited disease
- Measurement of health status in children with juvenile rheumatoid arthritis
- The pharmacokinetics of Norpace.
- The frequency of lysosomal storage diseases in The Netherlands
- Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration
- A six-minute walk test for assessing exercise tolerance in severely ill children
- Bone-Marrow Transplantation in the Maroteaux–Lamy Syndrome (Mucopolysaccharidosis Type VI)
- An update on the frequency of mucopolysaccharide syndromes in British Columbia